Skip to content
Finance Investment, Women

Australia’s Progress to Gender Equality Strengthens but Uncertainty Presents Challenges

Financy 4 mins read

MEDIA RELEASE: Friday 0600 AEDT, March 7, 2025

 

The latest scorecard on financial gender equality in Australia, the Financy Women's Index (FWX), has recorded the strongest annual progress since December 2021, with Australia's journey to equality gaining momentum in 2024 despite an uncertain outlook.

 

The FWX score rose to 77.59 points out of 100 in the December quarter, up from 76.83 points in December 2023.

 

The result was helped by three key data points: a record number of women on ASX 200 Boards; a narrowing of the gender gap in Unpaid Work; and female employment growth, with the FWX Employment sub-index rising to the highest it’s been since June 2023.

 

“The Financy Women’s Index showed further progress towards financial equality for women in Australia, but we have a lot further to go - particularly in areas like education and unpaid work,” says Dr Shane Oliver, Chief Economist at AMP.

 

“It’s also critical that the outcome of the upcoming Federal election maintains this progress and doesn’t see a backsliding in flexible working arrangements which risks making it harder for women to participate fully in the workforce.

 

“Making it harder for women to participate in the workforce would likely mean less female labour market participation which could mean lower economic activity than would otherwise be the case and a risk of higher inflation flowing from the smaller labour force. It could also threaten the economy’s ability to respond to the pressures of an aging population which will mean more consumers for each worker,” says Dr Oliver.

 

Over the past two decades, gender financial equality has been shaped by factors such as economic conditions, corporate sentiment, and government policies, says Bianca Hartge-Hazelman, author of the Financy Women’s Index.

 

She says that notably, the Workplace Gender Equality Act, introduced in 2012 under Julia Gillard’s government, laid the foundation for corporate-level change.

 

“Following this, we saw significant FWX growth in 2013 (3%), as the Act took effect, and again in 2018 (3%) during the Me Too movement, which spurred corporate action on gender equality,” Ms Hartge-Hazelman says.

 

“The current pace of progress in gender equality depends on consistent policy support and corporate commitment.

 

“We’ve seen over the past two decades how political shifts can influence outcomes, and the upcoming election will be critical in determining the trajectory for years to come.

 

“However, challenges remain with persistent cost of living pressures, a looming Federal Election, proposals to unwind flexible work in the public sector, and the re-election of US President Donald Trump.  These factors -particularly Trump’s attack on Diversity, Equity and Inclusion, mean there is greater uncertainty and concern about the outlook for gender equality,” Ms Hartge-Hazelman says.

 

Nicki Hutley, Consulting Economist, notes that at the last election, concerns about gender equity rose to the fore.

 

“Since then, we've seen the introduction of some great initiatives such as better pay for aged and childcare workers, more support for childcare and superannuation on paid parental leave.

 

“But we still have a long way to go, as this quarter's FWX shows, and it's critical that the next government continues to support gender equality progress, rather than undermining it,” Ms Hutley says.

 

Of the FWX sub-indices that drove the improvement, the FWX Employment sub-index rose to 73.6 points in December 2024 from 73.5 points in the previous year.

 

The FWX Unpaid Work sub-index rose to 69.8 points, compared to 67.8 points based on the latest available data from the Household, Income and Labour Dynamics in Australia (HILDA) Survey. The latest data shows that whilst women still do the bulk of unpaid care and housework each week, they’re doing less, and men are doing more hours than before.

 

The FWX Gender Pay Gap sub-index barely changed in 2024 and stood at 88.1 points in the December quarter, versus 88 points in December 2023. Female wages grew slightly faster than male wages at the start of the year, before the end of the year saw men’s wages accelerate and the national gender pay gap widened to 11.9% from 11.5%.

 


Key Facts:

·        Progress to gender equality improved in 2024, with the FWX rising 0.76 points to 77.59 in December, up from 76.83 in December 2023.

·        This is the strongest year-on-year progress since December 2021.

  • Key drivers of progress in 2024 include record ASX 200 Board representation for women, better employment levels, and a reduced gender gap in unpaid work as men took on more housework and childcare.
  • Timeframes to gender equality improved, with ASX 200 Board parity expected in 5 years. Pay parity is forecast in 21.7 years, superannuation in 17.7 years, underemployment in 21.4 years, employment in 24.5 years, unpaid work in 42.4 years, and education in 348.6 years.
  • Ahead of International Women’s Day 2025, rising living costs, a Federal Election, and US President Trump’s anti-DEI stance create uncertainty for gender equality progress. These dynamics may influence momentum in the coming years.

About us:

The Financy Women’s Index TM (FWX) is a quarterly measurement of the economic progress of women and timeframes to gender equality in Australia. The FWX is produced by Financy, which is a data-driven Communications & Social Impact Advocacy company. The Women’s Index is supported by an Advisory Committee which includes Dr Shane Oliver, Simone Cheung, Roger Wilkins, Leonora Risse, Bruce Hockman, Rhiannon Yetsenga and Nicki Hutley. The Index is proudly sponsored by NGS Super, Aspire Planning, Seven Consulting, HeirWealth and PritchittBland Communications.


Contact details:

Bianca Hartge-Hazelman
Author Financy Women’s Index:

M: 0403 656 399

E: [email protected]

 

 

Nicki Hutley  

Consulting Economist

M: 0410 587 586

E: [email protected]

Media

More from this category

  • Finance Investment
  • 13/01/2026
  • 13:40
Moomoo

Focused on AI, Australian investors expect 2026 to deliver

SYDNEY, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Australian investors have started the new year with an overwhelming appetite for artificial intelligence and expectations of solid returns from their increasingly global portfolios, a comprehensive new survey by stock broking firm Moomoo Australia and New Zealand reveals.The detailed survey of more than 600 Australian investors' expectations and intentions for the year complements the release of moomoo's 2026 Market Outlook today, where our local experts and global research team analyse key trends in financial markets for the year ahead.And this year, investors are committing to high-growth sectors, including AI – showing a willingness…

  • Finance Investment, Oil Mining Resources
  • 13/01/2026
  • 10:22
Jane Morgan Management

Patriot Resources reports significant silver and gold results validating Kitumba polymetallic target in Zambia

Perth, Australia – 13 January 2026: Patriot Resources Limited (ASX: PAT) has reported significant silver and gold assay results from its Phase 1 trenching program at Target B1 within the Company’s 80%-owned Kitumba 27715 Project in Zambia, further validating the prospect as a near-surface polymetallic system. The latest results add silver and gold credits to previously announced strong copper, zinc and lead geochemistry, reinforcing the scale and potential economic significance of the mineralised system. The Company said the combination of metals highlights a unique polymetallic signature and strengthens confidence in Target B1 as a priority focus for ongoing exploration. Notable…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 13/01/2026
  • 10:09
Jane Morgan Management

NeuroScientific Biopharmaceuticals (ASX:NSB) Reports Clinical Response for StemSmart(TM) Treatment in Fistulising Crohn’s Disease Under Special Access Program

13 January 2026 – Perth, Australia | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has today announced a “Clinical Response” from patients treated with its patented StemSmart™ Mesenchymal Stem Cell (MSC) therapy under the Therapeutic Goods Administration’s (TGA) Special Access Scheme (SAS) for fistulising Crohn’s disease. Three of four patients treated in Cohort 1 of the Special Access Program demonstrated a successful “Clinical Response” following treatment with StemSmart™, with the fourth patient showing a partial response with further clinical assessment needed. A Clinical Response is defined as either closure of at least 50 per cent of fistula openings or a reduction in fistula…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.